Healthcare Global Enterprises Ltd.
NSE: HCG | BSE: 539787
₹654.80
₹5.80
(0.89%)
As on 03-Jul-2026IST
Market cap
₹9,828 Cr
Revenue (TTM)
₹2,545 Cr
P/E Ratio
714.2
P/B Ratio
7.4
Div. Yield
0 %
Quality Score
1/10
Growth Score
7/10
Valuation Score
3/10
Momentum Score
8/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹14 Cr
-
ROE
5.7 %
-
ROCE
12.4 %
-
Industry P/E
50.78
-
EV/EBITDA
20.8
-
Debt to Equity
0.4
-
Book Value
₹89.2
-
EPS
₹8.7
-
Face value
10
-
Shares outstanding
149,302,203
10 Years Aggregate
CFO
₹1,684.86 Cr
EBITDA
₹1,938.97 Cr
Net Profit
₹-188.49 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Healthcare Global
| -0.5 | 3.7 | 24.1 | 23.2 | 27.4 | 24.4 | 13.7 |
|
BSE Sensex
| -8.2 | 4.2 | 6.1 | -6.8 | 6.3 | 8.2 | 11.1 |
|
BSE Healthcare
| 15.3 | 8.2 | 21.1 | 13.1 | 24.7 | 14.0 | 12.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Healthcare Global
| 36.5 | 33.9 | 27.2 | 20.2 | 45.5 | 56.1 | -46.3 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsNews & Analysis
All News
1 min read•By Research Desk
How did MFs fare as anchor investors?
4 min read•By Kumar Shankar Roy
About Healthcare Global
HealthCare Global Enterprises Limited provides medical and healthcare services in India and internationally. The company offers cancer diagnostics services, including genomics and molecular diagnostics, digital PET, preventive oncology, physical... examination, laboratory tests, home health services, digital pathology, and CTC detection; treatment services, such as medical oncology and haemato-oncology, radiation and surgical oncology, molecular imaging and theranostics, chemotherapy, robotic surgery, actinium and lutetium therapy, immunotherapy, psycho-oncology, targeted drug therapy, bone marrow transplant, pediatric oncology, organ preservation and reconstructive surgery, endocrine therapy, and liver transplant; and post care services comprising patient care, psychological support, nutrition and dietetics, multidisciplinary rehabilitation, and genetic counselling. It also provides cancer screening, interventional radiology, MRI, nephrology, clinical trial, hormone therapy, hematology, CAR T cell, translational and nuclear medicine, oncodermatology, anaesthesiology, paediatric and gynaecologic oncology, orthopaedic oncology, uro-oncology, infectious diseases, gastrointestinal and thoracic oncology, breast surgical oncology, clinical pharmacology, and pain and palliative services. In addition, the company operates multi-specialty hospitals under the HCG brand that offers inpatient and outpatient treatments with specialties in cardiology, neurology, orthopaedics, gastroenterology, urology, internal medicine and pulmonary, and critical care. Further, it provides oncology diagnostics services, including biomarker and translational research, and clinical research services under the Triesta Sciences brand; and fertility treatment services, including reproductive medicine, assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. HealthCare Global Enterprises Limited was founded in 1989 and is headquartered in Bengaluru, India. Read more
-
Incorporated
1998
-
Chairman
B S Ajai Kumar
-
Managing Director
--
-
Group
HCG
-
Headquarters
Bengaluru, Karnataka
-
Website
Looking for more details about Healthcare Global Enterprises Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
FAQs for Healthcare Global
What is the current share price of Healthcare Global Enterprises Ltd Today?
The share price of Healthcare Global Enterprises Ltd is ₹654.80 (NSE) and ₹658.25 (BSE) as of 03-Jul-2026 IST. Healthcare Global Enterprises Ltd has given a return of 27.42% in the last 3 years.
What is the current PB & PE ratio of Healthcare Global Enterprises Ltd?
The P/E ratio of Healthcare Global Enterprises Ltd is 714.23 times as on 03-Jul-2026, a 1307 premium to its peers’ median range of 50.78 times.
The P/B ratio of Healthcare Global Enterprises Ltd is 7.38 times as on 03-Jul-2026, a 0 premium to its peers’ median range of 7.38 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
168.91
|
8.33
|
|
2024
|
97.83
|
5.83
|
|
2023
|
123.76
|
4.31
|
|
2022
|
69.40
|
4.34
|
|
2021
|
0.00
|
3.70
|
What is the 52 Week High and Low of Healthcare Global Enterprises Ltd?
The 52-week high and low of Healthcare Global Enterprises Ltd are Rs 799.71 and Rs 513.30 as of 04-Jul-2026.
What is the market cap of Healthcare Global Enterprises Ltd?
Healthcare Global Enterprises Ltd has a market capitalisation of ₹ 9,828 Cr as on 03-Jul-2026. As per SEBI classification, it is a company.
Should I invest in Healthcare Global Enterprises Ltd?
Before investing in Healthcare Global Enterprises Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.